DRKS00010785已完成不适用
Trial on radical upfront surgery in advanced ovarian cancer in Germany extended part for fragility and long term quality of life - AGO-OVAR 19
AGO Research GmbH / AGO-Study Group0 个研究点目标入组 444 人开始时间: 2016年7月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 444
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Female
入选标准
- •First and second part of the study:
- •Suspected invasive or histologically confirmed, primary epithelial ovarian cancer, fallopian tube carcinoma or primary peritoneal carcinoma. Cytological diagnosis and/or biopsy before study participation are allowed.
- •Signed written informed consent obtained prior to registration.
- •Females aged = 18 years
- •Suspected FIGO stage IIB - IVB (all grades and all histological types)
排除标准
- •First and second part of the study:
- •Malignancy of non-epithelial origin of the ovary, the fallopian tube or the peritoneum.
- •Borderline tumours (tumours of low malignant potential) and FIGO stage IA – IIA tumours
- •Recurrent ovarian cancer.
- •Definitive cytoreductive surgery prior to signed informed consent.
- •Prior systemic antineoplastic therapy for ovarian cancer (for example chemotherapy, monoclonal antibody therapy, tyrosine-kinase-inhibitor therapy and/or hormonal therapy).
- •Dementia or significantly altered mental status, that would prohibit the understanding and giving of informed consent
- •Any reasons interfering with regular follow-up.
研究者
相似试验
进行中（未招募）
不适用
Trial on Radical Upfront Surgery in Advanced Ovarian CancerOvarian CancerNCT02828618AGO Study Group797
招募中
不适用
aparoscopic surgical staging for early ovarian cancerearly ovarian cancerJPRN-UMIN000039455Mie University, Graduate School of Medicine10
尚未招募
3 期
Randomised trial comparing Upfront surgery versus chemoradiotherapy (CCRT) in Head and Neck squamous cell carcinoma of unknown primary with neck node metastasis:CTRI/2021/01/030749TATA MEMORIAL HOSPITA
尚未招募
不适用
Sterotactic radiotherapy and chemotherapy to improve surgical resection and reduce recurrenceCTRI/2019/09/021082Tata Memorial Hospital
进行中（未招募）
不适用
Feasibility and safety of preoperative glucose control in patients with type 2 diabetes undergoing cardiovascular surgeryThe objective of this study is to investigate whether a targeted preoperative glucose control before planned cardiac surgery by i.v. insulin infusion (intensified glycemic control, ICG) versus standard care improves postoperative outcome in patients with T2DM. In addition to evaluating involved molecular mechanisms, this study should also strengthen the evidence of guidelines regarding perioperative glucose management of patients with T2DM.EUCTR2014-000980-42-ATMedical University Vienna40